Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, ARS Pharmaceuticals Inc’s stock clocked out at $14.00, up 4.63% from its previous closing price of $13.38. In other words, the price has increased by $4.63 from its previous closing price. On the day, 1.02 million shares were traded. SPRY stock price reached its highest trading level at $14.04 during the session, while it also had its lowest trading level at $13.25.
Ratios:
To gain a deeper understanding of SPRY’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.50 and its Current Ratio is at 12.54. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On August 13, 2024, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also upped its target price recommendation from $18 to $22.
Leerink Partners reiterated its Outperform rating for the stock on August 12, 2024, while the target price for the stock was revised from $19 to $20.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 19 ’24 when Lowenthal Richard E sold 100,000 shares for $13.95 per share. The transaction valued at 1,394,960 led to the insider holds 1,198,499 shares of the business.
Tanimoto Sarina sold 100,000 shares of SPRY for $1,394,960 on Nov 19 ’24. The CHIEF MEDICAL OFFICER now owns 1,198,499 shares after completing the transaction at $13.95 per share. On Nov 15 ’24, another insider, Chakma Justin, who serves as the Officer of the company, bought 236,380 shares for $17.30 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRY now has a Market Capitalization of 1360596992 and an Enterprise Value of 1153930624. For the stock, the TTM Price-to-Sale (P/S) ratio is 553.95 while its Price-to-Book (P/B) ratio in mrq is 6.77. Its current Enterprise Value per Revenue stands at 449.35 whereas that against EBITDA is -19.091.
Stock Price History:
Over the past 52 weeks, SPRY has reached a high of $18.51, while it has fallen to a 52-week low of $4.65. The 50-Day Moving Average of the stock is -5.25%, while the 200-Day Moving Average is calculated to be 27.67%.
Shares Statistics:
It appears that SPRY traded 1.08M shares on average per day over the past three months and 1679680 shares per day over the past ten days. A total of 96.41M shares are outstanding, with a floating share count of 50.74M. Insiders hold about 47.89% of the company’s shares, while institutions hold 42.07% stake in the company. Shares short for SPRY as of 1730332800 were 12597445 with a Short Ratio of 11.69, compared to 1727654400 on 11097485. Therefore, it implies a Short% of Shares Outstanding of 12597445 and a Short% of Float of 24.490000000000002.
